# S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer

> **NCT00686166** · PHASE2 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 83 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **BIOLOGICAL:** cetuximab
- **DRUG:** capecitabine
- **DRUG:** oxaliplatin
- **PROCEDURE:** therapeutic surgical procedure
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00686166
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2014-07
- **Final completion:** 2018-03
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2018-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00686166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00686166, "S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00686166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*